Ryvu Therapeutics presents clinical and preclinical data on RVU120, RVU305, and novel synthetic lethality programs at the 2024 EORTC-NCI-AACR Symposium
| Show full article |
|
This functionality is available for registred users only
|
-
Full nameRyvu Therapeutics SA
-
Registration countryPoland
-
IndustryPharmaceutical Preparation and Biotechnology
-
М/S&P/F
*** /*** /***









